PERSPECTA

News from every angle

← Back to headlines

AbbVie Reports Mixed Q1 Drug Revenues

AbbVie's Q1 revenues showed a 39% decline for Humira, while Skyrizi increased by 31% and Rinvoq by 23% year-over-year.

29 Apr, 12:04 — 29 Apr, 12:04
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed126d ago

AbbVie in charts: Q1 Revenues from Humira -39%, Skyrizi +31%, Rinvoq +23% Y/Y

Read full article →

Related Stories

South Korea Reports Record $14.3 Billion Surge in Foreign Reserves

3h ago

Chevron and Eni Expand Oil Operations in Venezuela Following US Deal

5h ago

Trump Says He Is Pleased Harry and Meghan Moved to the UK

5h ago

Yen Surges Amid Renewed Speculation of Japanese Intervention

10h ago